SCHEMBL6529611

SCHEMBL6529611

O=C(O)Oc1ccc2c(c1)nc(NCc1cccnc1)n2C1CCCCCC1

nearest known ligand 0.43

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
EGFR P00533 3/20 0.43
ADORA2A P29274 1/20 0.42
ADORA2B P29275 1/20 0.42
PDE9A O76083 2/20 0.41
OPRM1 P35372 2/20 0.41
OPRD1 P41143 2/20 0.41
OPRK1 P41145 2/20 0.41
OGFRL1 Q5TC84 2/20 0.41
TSHR P16473 2/20 0.41
OPRL1 P41146 1/20 0.41
KDM4E B2RXH2 1/20 0.41
FPR1 P21462 2/20 0.40
TP53 P04637 1/20 0.40
CYP1A2 P05177 1/20 0.40
CYP3A4 P08684 1/20 0.40
CYP2C9 P11712 1/20 0.40
CYP2C19 P33261 1/20 0.40
GSK3B P49841 1/20 0.40
NAMPT P43490 1/20 0.39
EPHX1 P07099 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6528420 0.91 OGFRL1 (0.47) OPRM1OPRD1OPRK1OGFRL1OPRL1
SCHEMBL6532046 0.89 OPRM1 (0.41) OPRM1OPRD1OPRK1OGFRL1OPRL1
SCHEMBL6529610 0.86 L3MBTL1 (0.54) EGFRPDE9AOPRM1OPRK1OGFRL1
SCHEMBL6530899 0.86 OPRM1 (0.43) EGFROPRM1OPRD1OPRK1OGFRL1
SCHEMBL6530894 0.83 OGFRL1 (0.46) OPRM1OPRD1OPRK1OGFRL1OPRL1
SCHEMBL6532520 0.83 ALDH1A1 (0.47) EGFROPRM1OPRD1OPRK1OGFRL1
SCHEMBL6527860 0.83 BRD4 (0.46) OPRM1OPRD1OPRK1OGFRL1OPRL1
SCHEMBL6530969 0.81 OGFRL1 (0.44) OPRM1OPRD1OPRK1OGFRL1OPRL1
SCHEMBL6528355 0.80 IDH1 (0.41) OPRM1OPRD1OPRK1OGFRL1OPRL1
SCHEMBL6530972 0.80 LMNA (0.44) PDE9AOPRM1OPRD1OPRK1OGFRL1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2005019186-A1 2-AMINOBENZIMIDAZOLE DERIVATIVES FOR USE IN THE TREATMENT OF HIV/AIDS BAYER HEALTHCARE AG (DE) 2005-03-03 WO disclosed